Health Highlights: April 12, 2022
New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
Related Posts
Casi 1 de cada 10 trasplantes de pulmón de EE. UU. se debe ahora a la COVID
JUEVES, 27 de enero de 2022 (HealthDay News) -- La COVID-19 está cambiando la...
Shift Work Might Delay Menopause, With Potential Harms to Health
THURSDAY, March 24, 2022 (HealthDay News) -- Women whose jobs require shift work...
ASTRO: Sexual Function After Brachytherapy Less Often Assessed in Women
MONDAY, Oct. 31, 2022 (HealthDay News) -- Women are less likely than men to be...
Flu Vaccine Uptake Varies by Sociodemographic Factors in CKD Patients
TUESDAY, Sept. 26, 2023 (HealthDay News) -- Among patients with chronic kidney...